Gentetics, environment and determinants of autoimmune diseases;Génétique, environnement et déterminisme des maladies auto-immunitaires

Revue Medicale de Liege

Volumn 67, Issue 5-6, 2012, Pages 263-272

  Moutschen, M ^a,b,c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c GIGA   (Belgium)

Author keywords

Autoimmune disease; Autoimmunity; Environment; Genetics; HLA; Tolerance

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; ENVIRONMENT; ENVIRONMENTAL FACTOR; GENETICS; HEREDITY; IPEX SYNDROME; REVIEW;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE SUSCEPTIBILITY; ENVIRONMENT; GENE-ENVIRONMENT INTERACTION; HLA ANTIGENS; HUMANS; INFECTION; LIFE STYLE; LYMPHOCYTE ACTIVATION; MULTIFACTORIAL INHERITANCE;

EID: 84863662950     PISSN: 0370629X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Begovich AB, Carlton V.E, Honigberg LA, et al. - An auto-immune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet, 1997, 17, 399-403.
2. Nagamine K, Peterson P, Scott HS, et al. - Positional cloning of the APECED gene. Nat Genet, 1997, 17, 393-398.
3. Anderson MS, Venanzi ES, Klein L, et al. - Projection of an immunological self shadow within the thymus by the aire protein. Science, 2002, 298, 1395-1401. (Pubitemid 35346134)
4. Giraud M, Yoshida H, Abramson J, et al. - Aire unleashes stalled RNA polymerase to induce ectopic gene expression in thymic epithelial cells. Proc Natl Acad Sci U S A, 2012, 109, 535-540.
5. Bennett CL, Christie J, Ramsdell F, et al. - The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet, 2001, 27, 20-21. (Pubitemid 32044513)
6. Gavin MA, Rasmussen JP, Fontenot JD, et al. - Foxp3-dependent programme of regulatory T-cell differentiation. Nature, 2007, 445, 771-775. (Pubitemid 46279714)
7. Berkel AI, Petry F, Sanal O, et al. - Development of systemic lupus erythematosus in a patient with selective complete C1q deficiency. Eur J Pediatr, 1997, 156, 113-115. (Pubitemid 27049154)
8. Schejbel L, Skattum L, Hagelberg S, et al. - Molecular basis of hereditary C1q deficiency - revisited : identification of several novel disease-causing mutations. Genes Immun, 2011, 12, 626-634.
9. Cheng MH, Anderson MS. - Monogenic auto-immunity. Annu Rev Immunol, 2012, 30, 393-427.
10. Snir O, Rieck M, Gebe JA, et al. - Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum, 2011, 63, 2873-2883.
11. Ben Dror L, Barnea E, Beer I, et al. - The HLA-B*2705 peptidome. Arthritis Rheum, 2010, 62, 420-429.
12. Breur-Vriesendorp BS, Dekker-Saeys AJIvanyi P. - Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann Rheum Dis, 1987, 46, 353-356. (Pubitemid 17068555)
13. Yin Y, Li Y, Kerzic MC, et al. - Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection. EMBO J, 2011, 30, 1137-1148.
14. Hahn M, Nicholson MJ, Pyrdol J, et al. - Unconventional topology of self peptide-major histocompatibility complex binding by a human auto-immune T cell receptor. Nat Immunol, 2005, 6, 490-496. (Pubitemid 41716762)
15. Bulek AM, Cole DK, Skowera A, et al. - Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes. Nat Immunol, 2012, 13, 283-289.
16. Mear JP, Schreiber KL, Munz C, et al. - Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J Immunol, 1999, 163, 6665-6670.
17. Bottini N, Musumeci L, Alonso A, et al. - A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet, 2004, 36, 337-338. (Pubitemid 38437254)
18. Begovich AB, Carlton VE, Honigberg LA, et al. - A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet, 2004, 75, 330-337. (Pubitemid 38943877)
19. Martorana D, Maritati F, Malerba G, et al. - PTPN22 R620W polymorphism in the ANCA-associated vasculitides. Rheumatology (Oxford), 2012, 51, 805-812.
20. Vang T, Congia M, Macis MD, et al. - Auto-immune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet, 2005, 37, 1317-1319. (Pubitemid 41722185)
21. Van der Auwera BJ, Vandewalle CL, Schuit FC, et al. - CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry. Clin Exp Immunol, 1997, 110, 98-103. (Pubitemid 27428521)
22. Karman J, Jiang JL, Gumlaw N, et al. - Ligation of cytotoxic T lymphocyte antigen-4 to the TCR inhibits T cell activation and directs differentiation into FOXP3+ regulatory T cells. J Biol Chem, 2012, Feb 15. [Epub ahead of print].
23. Schmechel S, Konrad A, Diegelmann J, et al. - Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status. Inflamm Bowel Dis, 2008, 14, 204-212. (Pubitemid 351288041)
24. Jiang Z, Yang P, Hou S, et al. - IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population. Ann Rheum Dis, 2010, 69, 1325-1328.
25. Farago B, Magyari L, Safrany E, et al. - Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann Rheum Dis, 2008, 67, 248-250. (Pubitemid 351183317)
26. Huber AK, Jacobson EM, Jazdzewski K, et al. - Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid auto-immunity. J Clin Endocrinol Metab, 2008, 93, 1077-1081. (Pubitemid 351398595)
27. Hemdan NY, Birkenmeier G, Wichmann G, et al. - Interleukin-17-producing T helper cells in auto-immunity. Auto-immun Rev, 2010, 9, 785-792
28. Gyulveszi G, Haak SBecher B. - IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo. Eur J Immunol, 2009, 39, 1864-1869.
29. Muranski P, Borman ZA, Kerkar SP, et al. - Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity, 2011, 35, 972-985.
30. Marshak-Rothstein A. - Toll-like receptors in systemic auto-immune disease. Nat Rev Immunol, 2006, 6, 823-835. (Pubitemid 44631651)
31. Shen N, Fu Q, Deng Y, et al. - Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A, 2010, 107, 15838-15843.
32. Huang CM, Huang PH, Chen CL, et al. - Association of toll-like receptor 9 gene polymorphism in Chinese patients with systemic lupus erythematosus in Taiwan. Rheumatol Int, 2011, Apr 17. [Epub ahead of print].
33. Duty JA, Szodoray P, Zheng NY, et al. - Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med, 2009, 206, 139-151.
34. Hugot JP, Chamaillard M, Zouali H, et al. - Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 2001, 411, 599-603. (Pubitemid 32531408)
35. Lasiglie D, Traggiai E, Federici S, et al. - Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients. PLoS One, 2011, 6, e20014.
36. Shaw PJ, McDermott MF, Kanneganti TD. - Inflammasomes and auto-immunity. Trends Mol Med, 2011, 17, 57-64.
37. Huang J, Brumell JH. - Autophagy in immunity against intracellular bacteria. Curr Top Microbiol Immunol, 2009, 335, 189-215.
38. Shi CS, Shenderov K, Huang NN, et al. - Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol, 2012, 13, 255-263.
39. Zhou XJ, Lu XL, Lv JC, et al. - Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population. Ann Rheum Dis, 2011, 70, 1330-1337.
40. Bogdanos DP, Smyk DS, Rigopoulou EI, et al. - Twin studies in auto-immune disease: Genetics, gender and environment. J Auto-immun, 2012, 38, J156-169.
41. Hedrich CM, Tsokos GC. - Epigenetic mechanisms in systemic lupus erythematosus and other auto-immune diseases. Trends Mol Med, 2011, 17, 714-724.
42. Lu Q, Wu ARichardson BC. - Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol, 2005, 174, 6212-6219. (Pubitemid 40663812)
43. Brooks WH. - X chromosome inactivation and autoimmunity. Clin Rev Allergy Immunol, 2010, 39, 20-29.
44. Kast RE. - Predominance of auto-immune and rheumatic diseases in females. J Rheumatol, 1977, 4, 288-292.
45. Fumagalli M, Pozzoli U, Cagliani R, et al. - Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to auto-immune conditions. J Exp Med, 2009, 206, 1395-1408.
46. Prugnolle F, Manica A, Charpentier M, et al. - Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol, 2005, 15, 1022-1027. (Pubitemid 40772149)
47. Rook GA. - Hygiene hypothesis and auto-immune diseases. Clin Rev Allergy Immunol, 2012, 42, 5-15.
48. Fleming JO, Isaak A, Lee JE, et al. - Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler, 2011, 17, 743-754.
49. Qin J, Li R, Raes J, et al. - A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 2010, 464, 59-65.
50. Atarashi KHonda K. - Microbiota in auto-immunity and tolerance. Curr Opin Immunol, 2011, 23, 761-768.
51. Ivanov, II, Atarashi K, Manel N, et al. - Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell, 2009, 139, 485-498.
52. Wu HJ, Ivanov, II, Darce J, et al. - Gut-residing segmented filamentous bacteria drive auto-immune arthritis via T helper 17 cells. Immunity, 2010, 32, 815-827.
53. Lee YK, Menezes JS, Umesaki Y, et al. - Proinflammatory T-cell responses to gut microbiota promote experimental auto-immune encephalomyelitis. Proc Natl Acad Sci U S A, 2011, 108 (Suppl 1), 4615-4622.
54. Kriegel MA, Sefik E, Hill JA, et al. - Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A, 2011, 108, 11548-11553.
55. Quintana FJ, Murugaiyan G, Farez MF, et al. - An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental auto-immune encephalomyelitis. Proc Natl Acad Sci U S A, 2010, 107, 20768-20773.
56. Wang HK, Yeh CH, Iwamoto T, et al. - Dietary flavonoid naringenin induces regulatory T cells via an aryl hydrocarbon receptor mediated pathway. J Agric Food Chem, 2012, 60, 2171-2178.
57. Kiss EA, Vonarbourg C, Kopfmann S, et al. - Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science, 2011, 334, 1561-1565.
58. Patterson RGermolec D. - Review article toxic oil syndrome: review of immune aspects of the disease. J Immunotoxicol, 2005, 2, 51-58.
59. Rieber N, Belohradsky BH. - AHR activation by tryptophan - pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome and toxic oil syndrome? Immunol Lett, 2010, 128, 154-155.
60. Kerkvliet NI, Steppan LB, Vorachek W, et al. - Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes. Immunotherapy, 2009, 1, 539-547.
61. Holladay SD, Mustafa AGogal RM, Jr. - Prenatal TCDD in mice increases adult auto-immunity. Reprod Toxicol, 2011, 31, 312-318.
62. Symmons DP, Bankhead CR, Harrison BJ, et al. -Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum, 1997, 40, 1955-1961. (Pubitemid 27494654)
63. Makrygiannakis D, Hermansson M, Ulfgren AK, et al. - Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis, 2008, 67, 1488-1492.
64. Yuk JM, Shin DM, Lee HM, et al. - Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe, 2009, 6, 231-243.
65. Adorini L, Penna G, Giarratana N, et al. - Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and auto-immune diseases. J Cell Biochem, 2003, 88, 227-233. (Pubitemid 36119891)
66. Leibowitz U, Sharon DAlter M. - Geographical considerations in multiple sclerosis. Brain, 1967, 90, 871-886.
67. Elliott JC, Lucas RM, Clements MS, et al. - Population density determines the direction of the association between ambient ultraviolet radiation and type 1 diabetes incidence. Pediatr Diabetes, 2010, 11, 394-402.
68. Zhang J, Li W, Liu J, et al. - Polymorphisms in the vitamin D receptor gene and type 1 diabetes mellitus risk: An update by meta-analysis. Mol Cell Endocrinol, 2012, 355, 135-142.
69. Maalej A, Petit-Teixeira E, Michou L, et al. - Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun, 2005, 6, 707-711. (Pubitemid 41741716)
70. Vogel A, Strassburg CP, Manns MP. - Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and auto-immune hepatitis. Hepatology, 2002, 35, 126-131. (Pubitemid 34032552)
71. Ritterhouse LL, Crowe SR, Niewold TB, et al. - Vitamin D deficiency is associated with an increased auto-immune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis, 2011, 70, 1569-1574.
72. Tauriainen S, Oikarinen S, Oikarinen M, et al. - Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol, 2011, 33, 45-55.
73. Vreugdenhil GR, Geluk A, Ottenhoff TH, et al. - Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule. Diabetologia, 1998, 41, 40-46. (Pubitemid 28105739)
74. Nejentsev S, Walker N, Riches D, et al. - Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science, 2009, 324, 387-389.
75. Farez MFCorreale J. - Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J Neurol, 2011, 258, 1197-1206.
76. DeStefano F, Mullooly JP, Okoro CA, et al. - Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics, 2001, 108, E112.
77. Vidal M, Cusick ME, Barabasi AL. - Interactome networks and human disease. Cell, 2011, 144, 986-998.